Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP444743.RABJhHt5QfvA0n4kVs8UJe_6jC627_NwhDF-dFRtPkGzo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP444743.RABJhHt5QfvA0n4kVs8UJe_6jC627_NwhDF-dFRtPkGzo130_assertion type Assertion NP444743.RABJhHt5QfvA0n4kVs8UJe_6jC627_NwhDF-dFRtPkGzo130_head.
- NP444743.RABJhHt5QfvA0n4kVs8UJe_6jC627_NwhDF-dFRtPkGzo130_assertion description "[Whereas individuals heterozygous for most alpha-chain mutations possess approximately 25% abnormal hemoglobin, heterozygotes for the alpha-chain variant Hb G Philadelphia synthesize either 33% or 50% Hb G. Both variable gene dosage and interaction with alpha-thalassemia have been proposed to explain this observation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP444743.RABJhHt5QfvA0n4kVs8UJe_6jC627_NwhDF-dFRtPkGzo130_provenance.
- NP444743.RABJhHt5QfvA0n4kVs8UJe_6jC627_NwhDF-dFRtPkGzo130_assertion evidence source_evidence_literature NP444743.RABJhHt5QfvA0n4kVs8UJe_6jC627_NwhDF-dFRtPkGzo130_provenance.
- NP444743.RABJhHt5QfvA0n4kVs8UJe_6jC627_NwhDF-dFRtPkGzo130_assertion SIO_000772 6935689 NP444743.RABJhHt5QfvA0n4kVs8UJe_6jC627_NwhDF-dFRtPkGzo130_provenance.
- NP444743.RABJhHt5QfvA0n4kVs8UJe_6jC627_NwhDF-dFRtPkGzo130_assertion wasDerivedFrom befree-20150227 NP444743.RABJhHt5QfvA0n4kVs8UJe_6jC627_NwhDF-dFRtPkGzo130_provenance.
- NP444743.RABJhHt5QfvA0n4kVs8UJe_6jC627_NwhDF-dFRtPkGzo130_assertion wasGeneratedBy ECO_0000203 NP444743.RABJhHt5QfvA0n4kVs8UJe_6jC627_NwhDF-dFRtPkGzo130_provenance.